Company Valuation: OneSource Specialty Pharma Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025 2026 2027 2028
Market Cap 1 2,00,521 1,77,965 - -
Change - -11.25% - -
Enterprise Value (EV) 1 2,00,521 1,80,604 1,86,821 1,79,129
Change - -9.93% -1.03% -4.12%
P/E -1,075x -229x 38x 18.4x
PBR - 3.04x 2.81x 2.48x
PEG - -1x -0x 0x
Capitalization / Revenue - 11.9x 8.16x 5.23x
EV / Revenue - 12.7x 8.57x 5.27x
EV / EBITDA - 59.4x 23.7x 13.1x
EV / EBIT - 719x 33.8x 17.4x
EV / FCF - -32.2x 33.8x 27.5x
FCF Yield - -3.1% 2.96% 3.64%
Dividend per Share 2 - - - -
Rate of return - - - -
EPS 2 -1.63 -6.44 40.5 83.73
Distribution rate - - - -
Net sales 1 - 14,216 21,798 34,019
EBITDA 1 - 3,042 7,875 13,689
EBIT 1 - 251.3 5,526 10,322
Net income 1 -179.7 -738 4,459 8,968
Net Debt 1 - 11,733 8,856 1,164
Reference price 2 1,752.25 1,537.80 1,537.80 1,537.80
Nbr of stocks (in thousands) 1,14,436 1,14,646 - -
Announcement Date 05/05/25 13/05/26 - -
1INR in Million2INR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-156.39x13.95x67.32x - 186.73Cr
33.15x5.95x17.82x0.98% 4.89TCr
-21.5x245.64x-23.19x-.--% 4.5TCr
34.48x3.33x14.35x-.--% 4.41TCr
46.93x5.41x29.72x-.--% 4.07TCr
28.42x8.6x21.8x0.4% 3.35TCr
33.62x5.51x25.02x-.--% 1.65TCr
24.24x2.11x9.11x1.11% 1.47TCr
77.18x4.06x15.75x-.--% 1.38TCr
Average 11.13x 32.73x 19.74x 0.31% 2.88TCr
Weighted average by Cap. 25.94x 47.12x 12.70x 0.3%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock
  4. Valuation OneSource Specialty Pharma Limited
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!